Program Description
Psoriasis is the most common immune-mediated inflammatory disease in North America and Europe, affecting approximately 8 million individuals in the United States and 125 million worldwide. Psoriasis is characterized by recurrent exacerbations and remissions of thickened, erythematous, and scaling plaques. Adopting a more aggressive treatment approach such as using systemic agents (ie, biologics) earlier with the goal of complete clearance may alter the normal progression of the disease, help more patients to attain long-term remission, and enhance long-term outcomes. Regardless of the accessibility of numerous treatment options and the continued development of efficacious therapies for psoriasis, nontreatment and undertreatment of patients continue to be a significant problem in the United States. A successful treatment regimen includes patient education and routine monitoring of patient response to therapy. In the setting of plaque psoriasis, pharmacists have an opportunity to exert a positive effect on patient outcomes via clinical intervention, patient education, and routine monitoring.
Target audience: Health-system, retail, and specialty pharmacists
Type of activity: Application
Release date: October 27, 2022
Expiration date: October 27, 2023
Time to complete activity: 1.0 hour
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Identify the risk factors, symptoms, and quality of life burden associated with plaque psoriasis
- Examine the role of novel and emerging therapies that address unmet needs in the treatment of plaque psoriasis
- Employ effective medication management and patient counseling approaches to improve outcomes for patients with plaque psoriasis
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
